What does Aeon do?
Aeon is an AI preventive health platform based in Zurich that integrates advanced diagnostic tools such as MRI scans, genetic and blood testing to enable early detection and personalized risk prediction for serious diseases.
How much did they raise?
The company raised €8.2M in a Seed funding round led by Concentric, with additional participation from Calm/Storm Ventures, GoHub, Kadmos, EWOR, and angel investor Daniel Gutenberg, positioning Aeon strongly for further expansion.
What are their plans for the money?
With the new capital, Aeon plans to expand operations across Switzerland, Germany, and the UK by opening over 10 new clinical locations. The funds will also be used to accelerate partnerships with insurers and employers, improving access and affordability of preventive healthcare.
What have they achieved so far?
Since its launch in 2024, Aeon has already made significant strides by detecting early-stage cancers, aneurysms, Alzheimer’s, and other critical conditions in asymptomatic individuals, and it has secured partnerships with major Swiss insurers including KPT.
